Indiana Governor's Bill Signing Ceremony Recognizes the Role of Meth-Resistant Technology in Stemming State Meth Problem
28. April 2016 06:15 ET
|
Acura Pharmaceuticals, Inc.
CULVER, IN--(Marketwired - April 28, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced that, today, Indiana...
Acura Pharmaceuticals to Host First Quarter 2016 Financial Results Conference Call on May 3, 2016
21. April 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - April 21, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
Acura Pharmaceutical's Limitx(TM) Technology Successfully Demonstrates Oral Abuse Deterrence
13. April 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - April 13, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline...
Acura Pharmaceuticals Announces FDA Fast Track Designation for the Development of LTX-04
12. April 2016 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - April 12, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.S. Food...
Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective
30. März 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - March 30, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced that its universal shelf registration statement on Form S-3, as amended, was declared...
Acura Pharmaceuticals Acknowledges Inclusion of Meth-Resistant Technology in Indiana Legislation
14. März 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - March 14, 2016) - On Thursday, March 10, 2016 the Indiana General Assembly passed legislation to require state pharmacists to use professional discretion when...
Acura Pharmaceuticals to Present at the 28th Annual ROTH Conference
08. März 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - March 08, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results
29. Februar 2016 16:30 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - February 29, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial...
Acura Pharmaceuticals to Host 2015 Financial Results Conference Call on March 1, 2016
22. Februar 2016 06:30 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - February 22, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
01. Februar 2016 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - February 01, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that clinical...